Provides functions and datasets from the book "Forest Analytics with R".

A toolkit for Flux Balance Analysis and related
    metabolic modeling techniques. Functions are provided for: parsing
    models in tabular format, converting parsed metabolic models to input
    formats for common linear programming solvers, and
    evaluating and applying gene-protein-reaction mappings. In addition, there
    are wrappers to parse a model, select a solver, find the metabolic fluxes,
    and return the results applied to the original model. Compared to other
    packages in this field, this package puts a much heavier focus on
    providing reusable components that can be used in the design of new
    implementation of new techniques, in particular those that involve large
    parameter sweeps. For a background on the theory, see What is Flux Balance 
    Analysis <doi:10.1038/nbt.1614>.

Provides a collection of functions to 
    explore and to investigate basic properties of financial returns 
    and related quantities.
    The covered fields include techniques of explorative data analysis
    and the investigation of distributional properties, including
    parameter estimation and hypothesis testing. Even more there are
    several utility functions for data handling and management.

Does family-based gene by environment interaction tests, joint gene, gene-environment interaction test, and a test of a set of genes conditional on another set of genes.

Performs dose assignment and trial simulation for the FBCRM (Fully Bayesian Continual Reassessment Method) and MFBCRM (Mixture Fully Bayesian Continual Reassessment Method) phase I clinical trial designs. These trial designs extend the Continual Reassessment Method (CRM) and Bayesian Model Averaging Continual Reassessment Method (BMA-CRM) by allowing the prior toxicity skeleton itself to be random, with posterior distributions obtained from Markov Chain Monte Carlo. On average, the FBCRM and MFBCRM methods outperformed the CRM and BMA-CRM methods in terms of selecting an optimal dose level across thousands of randomly generated simulation scenarios. Details on the methods and results of this simulation study are available on request, and the manuscript is currently under review.